Frequency of Hepatitis B Virus infection among Patients before Chemotherapy Treatment

BACKGROUND: Hepatitis B virus (HBV) is an important public health problem worldwide. Chronic HBV in patients undergoing chemotherapy and immunosuppressive treatment are at risk of HBV reactivation. The consequence of HBV reactivation in immunosuppressed patients may lead to liver failure and death....

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoudvand, Shahab, Shokri, Somayeh, Mirzaei, Habibollah, Ramezani, Ali, Makvandi, Manoochehr, Neisi, Niloofar, Hashemi, Sayed Jalal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850890/
https://www.ncbi.nlm.nih.gov/pubmed/34582665
http://dx.doi.org/10.31557/APJCP.2021.22.9.2939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850890/
https://www.ncbi.nlm.nih.gov/pubmed/34582665
http://dx.doi.org/10.31557/APJCP.2021.22.9.2939

Ejemplares similares